abstract |
The present invention provides novel combinations comprising phosphodiesterase-5 inhibitors and their use. The present invention relates to novel pharmaceutical methods for the treatment of various conditions. At least one phosphodiesterase-5-inhibitor in the following agents: selective serotonin reuptake inhibitors; serotonin-noradrenaline reuptake inhibitors; cholinesterase inhibitors; dopamine agonists; or in amino acids, monoamines, neuropeptides and synaptic clefts A composition comprising in combination with one or more of a drug suitable for increasing the chemical concentration of a neurotransmitter selected from other drugs capable of primary neurotransmission, and for the treatment of a neurodegenerative disease in a subject Their use for. [Selection] Figure 1 |